Azacitidine plus venetoclax as an alternative for hard-to-treat acute myeloid leukaemia patients Azacitidine plus venetoclax as an alternative for hard-to-treat acute myeloid leukaemia patients Clinical practice Read more
Clinical practice Podcast: The burden of CMV infection and real-life data of CMV prophylaxis Read more
Clinical practice Factors associated with the outcome of a second CD19-targeted CAR T cell infusion Read more
Clinical practice Research ties combining clarithromycin with direct oral anticoagulants to bleeding risk in eld... Read more
